BrightInsight Launches a CE-Marked Dosing Calculator for Emicizumab to Treat Patients with Hemophilia A
Shots:
- BrightInsight’s CE-marked dosing calculator enables health care professionals to determine the correct dosage & number of vials based on recommended dosage for the treatment of Hemophilia A with its development & distribution sponsored by Roche
- The calculator helps in determining the correct loading and maintenance dose of emicizumab based on BrightInsight’s Internet of Things platform providing digital health solutions
- The dosing Calculator is built under its ISO 13485:2016 Certified QMS and is a CE marked SaMD- used by healthcare professionals in Europe
Ref: Business Wire | Image: Chicago Tribune
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com